Inventor

DE BISWANATH

US60 patents

⚠️ This page may combine multiple inventors who share the name “DE BISWANATH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DE BISWANATH

PROCTER & GAMBLE

Aromatic C16-C20 substituted tetrahydro prostaglandins useful as FP agonists

Lactam-containing hydroxamic acids

Purine cytokine inhibitors

C16 unsaturated FP-selective prostaglandins analogs

2-decarboxy-2-phosphinico Prostaglandin F analogs

Substituted pyrrolidine hydroxamate metalloprotease inhibitors

Phosphinic acid amides as matrix metalloprotease inhibitors

Triazole compounds useful in treating diseases associated with unwanted cytokine activity

Triazole compounds useful in treating diseases associated with unwanted cytokine activity

Acyclic metalloprotease inhibitors

Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity

Pyrrolo[2,3-d]pyrimidine cytokine inhibitors

C16 unsaturated FP-selective prostaglandins analogs

C11 oxymyl and hydroxylamino prostaglandins useful as FP agonists

C11 oxymyl and hydroxylamino prostaglandins useful as medicaments

1,2-dihydropyrazol-3-ones which controls inflammatory cytokines

Aromatic C16 -C20 -substituted tetrahydro prostaglandins useful as FP agonists

6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

Substituted cyclic amine metalloprotease inhibitors

Hetero-substituted metalloprotease inhibitors

1,3-diheterocyclic metalloprotease inhibitors

Hetero-substituted cyclic amine metalloprotease inhibitors

Alkenyl- and alkynl-containing metalloprotease inhibitors

Heterocyclic metalloprotease inhibitors

1,3-diheterocyclic metalloprotease inhibitors

Spirocyclic containing hydroxamic acids useful as metalloprotease inhibitors

Spirocyclic-6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

1,5-heterocyclic metalloprotease inhibitors

Beta disubstituted metalloprotease inhibitors

Substituted cyclic amine metalloprotease inhibitors

Heterocyclic metalloprotease inhibitors

Diheterocyclic metalloprotease inhibitors

6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which provide analgesia

Bidentate metalloprotease inhibitors

Interleukin-1β converting enzyme inhibitors

Heterocyclic side chain containing, n-substituted metalloprotease inhibitors

Dihetero-substituted metalloprotease inhibitors

Fused pyrazolone compounds which inhibit the release of inflammatory cytokines

1,3-diheterocyclic metalloprotease inhibitors

ABBOTT LAB

Angiotensin II receptor antagonists

Angiotensin II receptor antagonists

Heterocycle-substituted benzyaminopyridine angiotensin II receptor antagonists

Luteinizing hormone releasing hormone antagonist

Heterocyclic renin inhibitors

Dopamine agonists

Heterocyclic peptide renin inhibitors

Candida acid protease inhibiting compounds

1,3-oxazolyl substituted biphenyl

Non-peptide renin inhibitors

(unassigned)

Aromatic C16 -C20 -substituted tetrahydro prostaglandins useful as FP agonists